Publikation

Leber's hereditary optic neuropathy mitochondrial DNA mutations in normal-tension glaucoma

Wissenschaftlicher Artikel/Review - 01.07.2001

Bereiche
PubMed

Zitation
Opial D, Flückiger F, Hirano M, Mermoud A, Munier F, Flammer J, Lietz-Partzsch A, Tadesse S, Boehnke M, Mojon D. Leber's hereditary optic neuropathy mitochondrial DNA mutations in normal-tension glaucoma. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie 2001; 239:437-40.
Art
Wissenschaftlicher Artikel/Review (Englisch)
Zeitschrift
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie 2001; 239
Veröffentlichungsdatum
01.07.2001
ISSN (Druck)
0721-832X
Seiten
437-40
Kurzbeschreibung/Zielsetzung

BACKGROUND: in Leber's hereditary optic neuropathy, increased optic nerve cupping has been reported by several authors. Recently, a mitochondrial DNA (mtDNA) mutation at nucleotide 11778 typically associated with Leber's hereditary optic neuropathy (LHON) was identified in a patient treated for glaucoma but lacking typical signs of LHON. The question arises: should all normal-tension glaucoma patients be further evaluated for LHON? METHODS: we screened 54 unselected patients with normal-tension glaucoma (age range 20-96 years, 16 men and 38 women) for the primary mtDNA LHON mutations at nucleotides 3460, 11778 and 14484. RESULTS: none of the patients harboured the mtDNA mutations at nucleotides 3460, 11778 or 14484 (95% confidence intervals for each mutation ranged from 0% to 5.3%). CONCLUSIONS: primary LHON mtDNA mutations are rare or absent in unselected normal-tension glaucoma patients. Therefore, unselected normal-tension glaucoma patients should not be screened for these mutations. It is probable that only normal-tension glaucoma patients with atypical features (rapid progression, early deep central scotoma, pallor of neuroretinal rim, elevated disc, peripapillary teleangiectasia) or a positive family history of visual loss compatible with a matrilinear transmission should be further evaluated.